omega-3 fatty acids in bur
Not Applicable
Recruiting
- Conditions
- mild burn.T20-T32
- Registration Number
- IRCT20231031059911N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Patients with mild burns or who with less than 20% of the body surface
Patients with a level of consciousness higher than 9
Exclusion Criteria
Age less than 18 and more than 65 years
Moderate to severe burns or involvement of less than 20% of the body surface
Patients who need parenteral nutrition
other diseases such as thyroid, cardiovascular, cancer, diabetes, kidney and liver disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose. Timepoint: At the The beginning of the study (before the start of the intervention) and 21 days after the start of consumption. Method of measurement: Laboratory.;Fasting insulin. Timepoint: At the The beginning of the study (before the start of the intervention) and 21 days after the start of consumption. Method of measurement: ELISA kit.;C-reactive protein. Timepoint: At the The beginning of the study (before the start of the intervention) and 21 days after the start of consumption. Method of measurement: ELISA kit.;Erythrocyte sedimentation rate. Timepoint: At the The beginning of the study (before the start of the intervention) and 21 days after the start of consumption. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method ength of hospital stay. Timepoint: from hospital admission to discarge. Method of measurement: counting the days.;Length of intensive care unit stay. Timepoint: From the beginning of hospitalization to discharge from the intensive care unit. Method of measurement: counting the days.